Print

Gentronix Limited Signs Three Year Agreement with GlaxoSmithKline (GSK) for GreenScreen HC and BlueScreen HC Genotoxicity Assays  
3/3/2010 10:38:26 AM

MANCHESTER, UK--(BUSINESS WIRE)--Gentronix Limited Manchester, UK announced today that it has entered into a three year agreement with GlaxoSmithKline (GSK) to provide GreenScreen HC and BlueScreen HC genotoxicity assays for use by GSK in genotoxicity screening.
//-->